$1.44
-0.07-4.64%
Pre-Market: 5:52 PM EDT
Comments
Loading...
Gelteq (NASDAQ:GELS) Stock Quotes, Forecast and News Summary
Gelteq Stock (NASDAQ: GELS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gelteq (GELS) stock?
You can purchase shares of Gelteq (NASDAQ:GELS) through any online brokerage.
Who are Gelteq (GELS) competitors?
Other companies in Gelteq’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).
What is the forecast, or price target, for Gelteq (GELS) stock?
There is no analysis for Gelteq to provide a consensus price target.
What is the current price for Gelteq (GELS)?
The stock price for Gelteq (NASDAQ: GELS) is $1.44 last updated November 20, 2024 at 5:52 PM EST.
Does Gelteq (GELS) pay a dividend?
There are no upcoming dividends for Gelteq.
When is Gelteq (NASDAQ:GELS) reporting earnings?
Gelteq’s Q4 earnings are confirmed for Saturday, February 15, 2025.
Is Gelteq (GELS) going to split?
There is no upcoming split for Gelteq.
What sector and industry does Gelteq (GELS) operate in?
Gelteq is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.